Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with meta-analysis and trial sequential analysis.

Hong DuoMengying JinYanwei YangRewaan BahetiYujia FengZirui FuYuyue JiangLanzhuoying ZhengJing WanHuaqin Pan

Published in: PloS one (2024)

According to the results of our sequential analysis, there is not enough evidence available to support or negate the use of antiplatelet agents in COVID-19 cases. The results of ongoing and future well-designed, large, randomized clinical trials are needed.

Keyphrases

antiplatelet therapy
coronavirus disease
sars cov
acute coronary syndrome
percutaneous coronary intervention
clinical trial
coronary artery disease
current status
phase iii
data analysis